Carlsmed Inc.
CARL | NASDAQ
$14.93
-$0.84 (-5.33%)
At close: Oct 30, 2026, 3:59 PM ET
$15.00
+$0.07 (+0.47%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Revenue | 50.51M | 27.17M | 13.78M |
Cost of Revenue | 12.47M | 7.12M | 3.88M |
Gross Profit | 38.04M | 20.05M | 9.9M |
Operating Income | -30.57M | -24.12M | -18.59M |
Interest Income | 2.7M | 1.33M | 334K |
Pretax Income | -29.63M | -24.26M | -18.9M |
Net Income | -29.63M | -24.26M | -18.9M |
Selling & General & Admin | 51.6M | 29.87M | 21.1M |
Research & Development | 17.02M | 14.3M | 7.4M |
Other Expenses | n/a | n/a | n/a |
Operating Expenses | 68.61M | 44.17M | 28.49M |
Interest Expense | 1.43M | 1.32M | 641K |
Selling & Marketing Expenses | 35.03M | 21.47M | 15.1M |
Cost & Expenses | 81.09M | 51.29M | 32.37M |
Income Tax Expense | n/a | n/a | n/a |
Shares Outstanding (Basic) | 14.22M | 16.56M | 4.45M |
Shares Outstanding (Diluted) | 14.22M | 16.56M | 4.45M |
EPS (Basic) | -2.12 | -1.50 | -4.25 |
EPS (Diluted) | -2.12 | -1.50 | -4.25 |
EBITDA | -27.92M | -22.79M | -18.12M |
EBIT | -28.2M | -22.94M | -18.26M |
Depreciation & Amortization | 281K | 145K | 136K |
Add to Watchlist
Select watchlists to add or remove CARL